Colon Transcriptomics Reveals Sex-Dependent Metabolic Signatures in Response to 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Treatment in C57BL/6N Mice.
PhIP metabolism
colonic transcriptome
lipolysis
mitochondrial dysfunction
sex-based difference
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Sep 2020
10 Sep 2020
Historique:
received:
23
07
2020
revised:
05
09
2020
accepted:
07
09
2020
entrez:
15
9
2020
pubmed:
16
9
2020
medline:
3
3
2021
Statut:
epublish
Résumé
Diets high in red meats, particularly meats cooked at high temperature, increase the risk of colon cancer due to a production of heterocyclic aromatic amines (HAAs). Of the identified HAAs, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is the most mass abundant colon carcinogen in charred meat or fish. Here, we comprehensively examined sex-dependent colon transcriptome signatures in response to PhIP treatment to identify biological discrepancies. Eight-week-old male and female C57BL/6N mice were intraperitoneally injected with PhIP (10 mg/kg of body weight) and colon tissues were harvested 24 h after PhIP injection, followed by colon transcriptomics analysis. A list of differentially expressed genes (DEGs) was utilized for computational bioinformatic analyses. Specifically, overrepresentation test using the Protein Analysis Through Evolutionary Relationships tool was carried out to annotate sex-dependent changes in transcriptome signatures after PhIP treatment. Additionally, the most significantly affected canonical pathways by PhIP treatment were predicted using the Ingenuity Pathway Analysis. As results, male and female mice presented different metabolic signatures in the colon transcriptome. In the male mice, oxidative phosphorylation in the mitochondrial respiratory chain was the pathway impacted the most; this might be due to a shortage of ATP for DNA repair. On the other hand, the female mice showed concurrent activation of lipolysis and adipogenesis. The present study provides the foundational information for future studies of PhIP effects on underlying sex-dependent mechanisms.
Identifiants
pubmed: 32927802
pii: ijms21186620
doi: 10.3390/ijms21186620
pmc: PMC7555907
pii:
doi:
Substances chimiques
2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine
0
Aminopyridines
0
Imidazoles
0
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Arkansas
ID : VPRED Start-up
Organisme : University of Delaware
ID : BHAN175183
Organisme : China Scholarship Council
ID : 201706910013
Organisme : National Research Foundation of Korea
ID : NRF-2019R1A2C1090007
Références
J Lipid Res. 1996 Apr;37(4):693-707
pubmed: 8732771
Mutat Res. 1990 Nov;245(3):185-90
pubmed: 2233839
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Carcinogenesis. 1991 Aug;12(8):1503-6
pubmed: 1860171
Oncol Rep. 2017 Oct;38(4):2105-2115
pubmed: 28765876
Cancer Res. 1995 Feb 1;55(3):525-9
pubmed: 7834621
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
Environ Mol Mutagen. 2002;40(2):116-21
pubmed: 12203404
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Carcinogenesis. 2005 Jan;26(1):229-38
pubmed: 15459021
Exp Biol Med (Maywood). 2017 Apr;242(8):813-839
pubmed: 28205448
Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27
pubmed: 18594563
Int J Cancer. 2016 Feb 15;138(4):976-82
pubmed: 26335255
Chem Sci. 2016 Jan 1;7(1):489-498
pubmed: 28791102
Nat Genet. 2002 Sep;32(1):180-4
pubmed: 12195423
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1105-10
pubmed: 19139408
Environ Mol Mutagen. 2004;44(1):44-55
pubmed: 15199546
Nature. 1994 Mar 17;368(6468):237-9
pubmed: 7511798
Mutat Res. 2002 Mar 20;500(1-2):157-68
pubmed: 11890945
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Food Chem Toxicol. 2002 Aug;40(8):1063-8
pubmed: 12067565
Arch Toxicol. 1994;68(2):129-33
pubmed: 8179482
Food Chem Toxicol. 2017 Aug;106(Pt B):583-594
pubmed: 27693244
Sci Signal. 2018 Apr 24;11(527):
pubmed: 29692362
J Biol Chem. 1994 Jun 17;269(24):16559-65
pubmed: 8206972
Cell Death Dis. 2017 Feb 2;8(2):e2593
pubmed: 28151470
Int J Cancer. 2011 Jun 1;128(11):2581-90
pubmed: 20715105
J Exp Clin Cancer Res. 2018 Jun 15;37(1):118
pubmed: 29907133
Science. 2015 Apr 3;348(6230):95-98
pubmed: 25838379
BMC Genomics. 2017 Jan 13;18(1):82
pubmed: 28086790
J Nutr. 2015 Mar;145(3):442-51
pubmed: 25733458
Carcinogenesis. 2001 Jul;22(7):1087-93
pubmed: 11408353
Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732
pubmed: 31455888
Acta Pharmacol Sin. 2001 Feb;22(2):148-54
pubmed: 11741520
Cancer Lett. 2005 Jun 28;224(2):279-88
pubmed: 15914278
J Biol Chem. 2019 May 10;294(19):7810-7820
pubmed: 30923124
Jpn J Cancer Res. 1989 Dec;80(12):1176-8
pubmed: 2516847
Genes Dev. 1999 Jan 15;13(2):152-7
pubmed: 9925639
Am J Cancer Res. 2014 Dec 15;5(1):191-200
pubmed: 25628930
Carcinogenesis. 1984 Oct;5(10):1257-62
pubmed: 6488447
Mutat Res. 1991 Mar-Apr;259(3-4):399-410
pubmed: 2017219
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Carcinogenesis. 2018 Jul 3;39(7):851-859
pubmed: 29726902
Oncogene. 2012 Jun 14;31(24):2931-42
pubmed: 22002314
Proc Natl Acad Sci U S A. 2011 May 31;108(22):8990-5
pubmed: 21576488
Carcinogenesis. 1996 Jan;17(1):95-8
pubmed: 8565143
Arch Toxicol. 2017 Oct;91(10):3415-3425
pubmed: 28289824
J Steroid Biochem. 1989 Jun;32(6):797-809
pubmed: 2547112
Mutat Res. 2001 Oct 1;482(1-2):3-10
pubmed: 11535243
Life Sci. 2011 Jul 18;89(3-4):65-71
pubmed: 21683715
Nutr Cancer. 2000;36(1):52-8
pubmed: 10798216